Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Vanrafia dosage?

See the DrugPatentWatch profile for Vanrafia

Vanrafia (aliskiren) – Typical Adult Dosage for Hypertension

Situation Typical Dose Notes
Initial therapy in patients with normal kidney function (GFR > 60 mL/min/1.73 m²) 150 mg orally once daily Can be increased after 4–6 weeks to a maximum of 300 mg once daily if needed.
Patients with mild–moderate renal impairment (GFR 30–60 mL/min/1.73 m²) 150 mg orally once daily No dose escalation.
Patients with severe renal impairment (GFR < 30 mL/min/1.73 m²), kidney transplant recipients, or patients on dialysis Not recommended Aliskiren is contraindicated.
Pregnancy Contraindicated Aliskiren is Category X; can cause fetal injury.
Children Not approved No data; use with caution.

How to Take It

  • Take once daily at the same time each day (morning is typical).
  • Can be taken with or without food.
  • Swallow the tablet whole; do not crush or chew.

Monitoring & Safety

  1. Blood pressure – Check regularly; adjust dose if needed.
  2. Serum creatinine & GFR – Re‑measure at least once every 4–6 weeks after starting or changing dose.
  3. Serum potassium – Monitor because aliskiren can increase potassium levels; avoid if hyperkalemia is present or if patient is on potassium‑sparing diuretics, ACE inhibitors, or ARBs.
  4. Renal function – Discontinue if GFR falls below 30 mL/min/1.73 m².
  5. Adverse events – Common: cough, dizziness, headache, diarrhea. Report any new or worsening symptoms.

Contraindications & Precautions

  • Diabetic patients with renal impairment – Use with caution; avoid if GFR < 60 mL/min/1.73 m².
  • Combination with ACE inhibitors or ARBs – Can increase risk of renal dysfunction and hyperkalemia.
  • Severe hepatic impairment – Not studied; use cautiously.
  • Pregnancy or lactation – Contraindicated.
  • Recent or ongoing kidney transplant – Contraindicated.

Key Take‑away: Start at 150 mg once daily; consider increasing to 300 mg only in patients with normal kidney function who need additional BP control, and only after 4–6 weeks of therapy. Avoid use in patients with severe kidney disease, kidney transplant recipients, pregnant women, and those with uncontrolled diabetes–related renal dysfunction. Regular monitoring of BP, kidney function, and potassium is essential for safe use.



Other Questions About Vanrafia :

Why doesn't vanrafia have a generic right now? Generic vanrafia available? Is there a generic version of vanrafia yet? Vanrafia cost? Vanrafia price?